Evidence of survival bias in the association between APOE-Є4 and age at ischemic stroke onset
- PMID: 39286457
- PMCID: PMC11403718
- DOI: 10.3389/fgene.2024.1392061
Evidence of survival bias in the association between APOE-Є4 and age at ischemic stroke onset
Abstract
Introduction: Large genome-wide association studies (GWASs) using case-control study designs have now identified tens of loci associated with ischemic stroke (IS). As a complement to these studies, we performed GWAS in a case-only design to identify loci influencing the age at onset (AAO) of ischemic stroke.
Methods: Analyses were conducted in a discovery cohort of 10,857 ischemic stroke cases using a linear regression framework. We meta-analyzed all SNPs with p-value <1 x 10-5 in a sexcombined or sex-stratified analysis using summary data from two additional replication cohorts.
Results: In the women-only meta-analysis, we detected significant evidence for the association of AAO with rs429358, an exonic variant in apolipoprotein E (APOE) that encodes for the APOE-Є4 allele. Each copy of the rs429358:T>C allele was associated with a 1.29-year earlier stroke AAO (meta p-value = 2.48 x 10-11). This APOE variant has previously been associated with increased mortality and ischemic stroke AAO. We hypothesized that the association with AAO may reflect a survival bias attributable to an age-related decrease in mortality among APOE-Є4 carriers and have no association to stroke AAO per se. A simulation study showed that a variant associated with overall mortality might indeed be detected with an AAO analysis. A variant with a 2-fold increase in mortality risk would lead to an observed effect of AAO that is comparable to what we found.
Discussion: In conclusion, we detected a robust association of the APOE locus with stroke AAO and provided simulations to suggest that this association may be unrelated to ischemic stroke per se but related to a general survival bias.
Keywords: APOE; age at onset; atherosclerosis; genome-wide association study; stroke.
Copyright © 2024 von Berg, McArdle, Häppölä, Haessler, Kooperberg, Lemmens, Pezzini, Thijs, Pulit, Kittner, Mitchell, de Ridder, van der Laan and FinnGen.
Conflict of interest statement
SWvdL received funding from Roche Diagnostics International Ltd for unrelated work. JdR is co-founder and director of Cyclomics, a genomics company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision
Figures



Update of
-
Evidence of survival bias in the association between APOE-ϵ4 and age of ischemic stroke onset.medRxiv [Preprint]. 2023 Dec 1:2023.12.01.23294385. doi: 10.1101/2023.12.01.23294385. medRxiv. 2023. Update in: Front Genet. 2024 Sep 02;15:1392061. doi: 10.3389/fgene.2024.1392061. PMID: 38076909 Free PMC article. Updated. Preprint.
References
-
- Adams H. P., Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., et al. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41. 10.1161/01.str.24.1.35 - DOI - PubMed
-
- Blauwendraat C., Heilbron K., Vallerga C. L., Bandres-Ciga S., von Coelln R., Pihlstrøm L., et al. (2019). Parkinson’s disease age at onset genome-wide association study: defining heritability, genetic loci, and α-synuclein mechanisms. Mov. Disord. 34, 866–875. 10.1002/mds.27659 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous